100 CORPORATE DRIVE, MAHWAH, NJ
KORU Medical Systems Enters Amendment to Loan and Security Agreement
CEO Retirement - Linda Tharby to Step Down; Kalbermatten Appointed
Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
KORU Medical Systems Amends By-Laws; Board Enhances Disclosure Requirements
Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
Amended Manufacturing and Supply Agreement with Command Medical Products
Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
Announces Q2 2025 Financial Results, Including Record Double-Digit Revenue, and Raises 2025 Revenue Guidance
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Amended Statement of Changes in Beneficial Ownership
Statement of Changes in Beneficial Ownership
S-8 POS
Correspondence
Submission Upload